Jeffrey A. Meckler, CEO and Director at Indaptus Therapeutics, Inc. (INDP), bought 9,692 shares at $2.44 ($25K) on 2022-09-06, disclosed to the SEC on 2022-09-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.44 | 1,060 | $3K | 10.4% |
| 2 | $2.57 | 8,632 | $22K | 89.6% |
| Total | $2.56 avg | 9,692 | $25K | 100% |
| Filing → |
| TVTX | SELL | 2024-09-30 | $562K | — | Filing → |
| INDP | BUY | 2022-11-22 | $19K | — | Filing → |
| INDP | BUY | 2022-09-12 | $29K | — | Filing → |